Phase I/II Study of 5-Aza-2'-Deoxycytidine and Valproic Acid in Patients With Relapsed/Refractory Leukemia or Myelodysplastic Syndromes.

Trial Profile

Phase I/II Study of 5-Aza-2'-Deoxycytidine and Valproic Acid in Patients With Relapsed/Refractory Leukemia or Myelodysplastic Syndromes.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 08 Jun 2012

At a glance

  • Drugs Decitabine; Valproic acid
  • Indications Leukaemia; Myelodysplastic syndromes
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 11 Aug 2009 Eisai Medical Research added as trial sponsor and lead trial centre as reported by ClinicalTrials.gov.
    • 09 Jun 2009 Actual end date changed from Feb 2006 to Nov 2006 as reported by ClinicalTrials.gov.
    • 09 Jun 2009 Planned number of patients changed from 60 to 54 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top